BiotechTube
Home/Replimune/Emily Hill
EH

Emily Hill

Chief Financial Officer

Replimune

Therapeutic Areas

OncologyImmuno-oncology

Replimune Pipeline

DrugIndicationPhase
RP1Advanced MelanomaPhase 2/3
RP2Metastatic Uveal MelanomaPhase 2/3

Leadership Team at Replimune

SP
Sushil Patel
Chief Executive Officer
KX
Kostas Xynos
Chief Medical Officer
CS
Chris Sarchi
Chief Commercial Officer
View full Replimune profile